Cidara Therapeutics, Inc. (CDTX) Stock Price, News, Quote & History - Yahoo Finance
Oops, something went wrong
Skip to navigation
Skip to main content
Skip to right column
News
Today's news
US
Politics
World
Weather
Climate change
Health
Wellness
Mental health Sexual health Dermatology Oral health Hair loss Foot health
Nutrition
Healthy eating Meal delivery Weight loss Vitamins and supplements
Fitness
Equipment Exercise
Women’s health
Sleep
Healthy aging
Hearing Mobility
Science
Originals
The 360
Newsletters
Games
Life
Health
Wellness
Nutrition Fitness Healthy aging Mental health Sleep
Your body
Dermatology Children's health Foot health Hair loss Hearing Oral health Sexual health Women’s health
Conditions
Cardiovascular health Digestive health Endocrine system
Parenting
Family health
So mini ways
Style and beauty
It Figures
Unapologetically
Horoscopes
Shopping
Style
Accessories Clothing Luggage Shoes
Beauty
Hair Makeup Skincare Sunscreen
Health
Dental Fitness Hair loss Hearing aids Mental health Mobility Nutrition Personal care Sleep Women's health
Home and garden
Bedding Cleaning Gardening Kitchen Outdoor
Pets
Tech
Accessories Audio Auto Computers Phones Smart home TVs
Gift ideas
Stores
Amazon Best Buy Home Depot Macy's Nordstrom Target Walmart Wayfair
Shopping Guides
Best non-toxic cutting boards Best heated socks Best body wash Best cordless stick vacuums Best makeup removers
Deals
Food
Travel
Autos
EV & Future Tech
Classic & Collector
Deals & Buying Guides
Ownership
Safety & Recalls
Policy & Environment
New Vehicles & Reviews
Auto Shows
General
People & Culture
Gift ideas
Buying guides
Best Prime Day deals
Prime Day tech deals
October Prime Day deals
Entertainment
Celebrity
TV
Movies
Music
How to Watch
Interviews
Videos
Finance
My Portfolio
News
Latest
Stock Market
Originals
Crypto
Tariff Updates
Newsletters
Economies
Premium News
Earnings
Tech
Housing
Markets
Stocks: Most Actives
Stocks: Gainers
Stocks: Losers
Trending Tickers
Futures
World Indices
US Treasury Bonds Rates
Currencies
Crypto
Top ETFs
Top Mutual Funds
Options: Highest Open Interest
Options: Highest Implied Volatility
Sectors
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Private Companies
Research
Screeners
Earnings Calendar
Economic Calendar
Stock Comparison
Advanced Chart
Currency Converter
Stock Picks
Investment Ideas
Research Reports
Personal Finance
Credit Cards
Banking
Student Loans
Personal Loans
Insurance
Mortgages
Mortgage Calculator
Taxes
Videos
Latest
Trending Stocks
Market Sunrise
Morning Brief
Opening Bid
All Shows
Stocks in Translation
Trader Talk
Financial Freestyle
ETF Report
FA Corner
Options Playbook
Watch Now
Sports
Fantasy
News
Fantasy football
Best ball
Pro Pick 'Em
College Pick 'Em
Fantasy baseball
Fantasy hockey
Fantasy basketball
Download the app
Daily fantasy
NFL
News
Scores and schedules
Standings
Stats
Teams
Players
Drafts
Injuries
Odds
Super Bowl
GameChannel
Videos
NBA
News
Draft
Scores and schedules
Standings
Stats
Teams
Players
Injuries
Videos
Odds
Playoffs
MLB
News
Scores and schedules
Standings
Stats
Teams
Players
Odds
Videos
World Baseball Classic
NHL
News
Scores and schedules
Standings
Stats
Teams
Players
Odds
Playoffs
College football
News
Scores and schedules
Standings
Rankings
Stats
Teams
College basketball
Soccer
News
Scores and schedules
Premier League
MLS
NWSL
Liga MX
CONCACAF League
Champions League
La Liga
Serie A
Bundesliga
Ligue 1
World Cup
NFL Draft
Yahoo Sports AM
Show all
WNBA
Sportsbook
NCAAF
Tennis
Golf
NASCAR
NCAAB
NCAAW
Boxing
USFL
Cycling
Motorsports
Olympics
Horse racing
GameChannel
Rivals
Newsletters
Podcasts
Videos
RSS
Jobs
Help
World Cup
More news
New on Yahoo
Creators
Tech
Audio
Computing
Gaming
Connections Gaming deals Nintendo PC PlayStation Wordle Xbox
Home entertainment
TVs
Phones
Science
Streaming
Streaming reviews
Tech News
VPN
Deals
More
AI Apps AR and VR Business Cameras Cyber security Entertainment General Reviews and guides Smart home Social media Transportation Wearables
Local services
Moving
Roofing
Painting
Plumbing
Terms
Privacy
Privacy Dashboard
Feedback
© 2025
All rights reserved.
About our ads
Advertising
Careers
Yahoo Finance
Yahoo Finance
Search query
Select edition
USEnglish
US y LATAMEspañol
AustraliaEnglish
CanadaEnglish
CanadaFrançais
DeutschlandDeutsch
FranceFrançais
香港繁中
MalaysiaEnglish
New ZealandEnglish
SingaporeEnglish
台灣繁中
UKEnglish
News
Finance
Sports
More
News
Today's news
US
Politics
World
Weather
Climate change
Health
Science
Originals
Newsletters
Games
Life
Health
Parenting
Style and beauty
Horoscopes
Shopping
Food
Travel
Autos
Gift ideas
Buying guides
Best Prime Day deals
Prime Day tech deals
October Prime Day deals
Entertainment
Celebrity
TV
Movies
Music
How to Watch
Interviews
Videos
Finance
My portfolio
Watchlists
Markets
News
Videos
Screeners
Personal finance
Crypto
Sectors
Sports
Fantasy
NFL
NBA
MLB
NHL
College football
College basketball
Soccer
NFL Draft
Yahoo Sports AM
New on Yahoo Creators Tech Local services
Selected edition
USEnglish
Mail
Sign in
My Portfolio
News
Latest Stock Market Originals Crypto Tariff Updates Newsletters Economies Premium News
Earnings Tech Housing
Markets
Stocks: Most Actives Stocks: Gainers Stocks: Losers Trending Tickers Futures World Indices US Treasury Bonds Rates Currencies Crypto Top ETFs Top Mutual Funds Options: Highest Open Interest Options: Highest Implied Volatility Sectors Basic Materials Communication Services Consumer Cyclical Consumer Defensive Energy Financial Services Healthcare Industrials Real Estate Technology Utilities Private Companies
Research
Screeners Earnings Calendar Economic Calendar Stock Comparison Advanced Chart Currency Converter Stock Picks
Investment Ideas
Research Reports
Personal Finance
Credit Cards Banking Student Loans Personal Loans Insurance Mortgages Mortgage Calculator Taxes
Videos
Latest Trending Stocks Market Sunrise Morning Brief Opening Bid All Shows Stocks in Translation Trader Talk Financial Freestyle ETF Report FA Corner Options Playbook
Watch Now
…
Upgrade to Premium
CDTX Cidara Therapeutics, Inc.
88.50
-0.09%
Summary
News
Research
Chart
Community
Statistics
Historical Data
Profile
Financials
Analysis
Options
Holders
Sustainability
We are experiencing some temporary issues. The market data on this page is currently delayed.
NasdaqCM - Nasdaq Real Time Price • USD
Cidara Therapeutics, Inc. (CDTX)
Follow
Add holdings
Get top stock picks
88.58
+15.09
+(20.53%)
At close: 4:00:01 PM EDT
88.50
-0.08
(-0.09%)
After hours: 5:29:16 PM EDT
Get top stock picks
Chart Range Bar
1D
5D
36.59%
1M
33.46%
6M
274.86%
YTD
229.54%
1Y
722.47%
5Y
54.86%
All
-72.51%
Key Events
Mountain
Advanced Chart
Loading chart for CDTX
Previous Close 73.49
Open 77.00
Bid 88.09 x 100
Ask 88.86 x 200
Day's Range 77.00 - 90.64
52 Week Range 10.14 - 90.64
Volume 3,332,321
Avg. Volume 736,385
Market Cap (intraday) 2.246B
Beta (5Y Monthly) 1.29
PE Ratio (TTM) --
EPS (TTM) -7.63
Earnings Date Nov 6, 2025
Forward Dividend & Yield --
Ex-Dividend Date --
1y Target Est 126.20
Cidara Therapeutics, Inc. Overview Biotechnology / Healthcare
Cidara Therapeutics, Inc. operates as a biotechnology company that focuses on developing targeted therapies for patients facing cancers and other serious diseases. The company's product includes rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also develops its Cloudbreak platform that enables development of novel drug-Fc conjugates, that includes CD388, a potent antiviral designed to deliver universal prevention and treatment of seasonal and pandemic influenza, which is in Phase 1 and Phase 2a clinical trials. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014. Cidara Therapeutics, Inc. was incorporated in 2012 and is based in San Diego, California. www.cidara.com
38 Full Time Employees December 31 Fiscal Year Ends Healthcare
Sector Biotechnology
Industry
More about Cidara Therapeutics, Inc.
Recent News: CDTX View More
All
News
Earnings Calls
Press Releases
SEC Filings
Why Cidara Therapeutics, Already Up 173% This Year, Just Hit A Seven-Year High
Investor's Business Daily • 1h ago
Sector Update: Health Care Stocks Decline Late Afternoon
PREMIUM MT Newswires • 1h ago
Update: Cidara's Phase 3 Trial of Influenza Prevention Drug CD388 to Begin in September; Shares Rise
PREMIUM MT Newswires • 4h ago
Cidara Therapeutics Announces Expanded and Accelerated Phase 3 Plan for CD388, a Non-Vaccine Preventative of Seasonal Influenza
GlobeNewswire • 10h ago
Cidara Therapeutics (CDTX) Upgraded to Buy: Here's What You Should Know
Zacks • 2d ago
Has Black Diamond Therapeutics (BDTX) Outpaced Other Medical Stocks This Year?
Zacks • 2d ago
Will Positive CD388 Influenza Data Shift Cidara Therapeutics’ (CDTX) Outlook for Prevention Therapies?
Simply Wall St. • 4d ago
Cidara Therapeutics Presents Data on CD388 from its Phase 2b NAVIGATE Trial and Preclinical Studies Against H5N1 at ISRV’s 8th AVG and 3rd IMRP 2025 Meeting
GlobeNewswire • 7d ago
Cidara Therapeutics to Participate in September Investor Conferences
GlobeNewswire • 20d ago
Cidara Therapeutics to Present Clinical Phase 2b Data and Preclinical H5N1 Data on CD388 at ISRV’s 8th AVG and 3rd IMRP 2025 Meeting
GlobeNewswire • 21d ago
Cidara Therapeutics Inc (CDTX) Q2 2025 Earnings Call Highlights: Promising Clinical Trial ...
GuruFocus.com • 1mo ago
View More
Performance Overview: CDTX
Trailing total returns as of 9/24/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC)
.
YTD Return
CDTX 229.54%
S&P 500 (^GSPC) 12.86%
1-Year Return
CDTX 722.47%
S&P 500 (^GSPC) 15.79%
3-Year Return
CDTX 561.04%
S&P 500 (^GSPC) 79.73%
5-Year Return
CDTX 54.86%
S&P 500 (^GSPC) 104.46%
Compare To: CDTX Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
CDTX Cidara Therapeutics, Inc.
88.58 +20.53%
Mkt Cap
2.246B
Industry Biotechnology
ABVX ABIVAX Société Anonyme
82.55 +0.65%
Mkt Cap
6.392B
Industry Biotechnology
NKTR Nektar Therapeutics
60.33 +1.22%
Mkt Cap
1.147B
Industry Biotechnology
SRRK Scholar Rock Holding Corporation
33.72 -0.09%
Mkt Cap
3.241B
Industry Biotechnology
SLNO Soleno Therapeutics, Inc.
64.50 +13.46%
Mkt Cap
3.428B
Industry Biotechnology
LRMR Larimar Therapeutics, Inc.
5.10 +14.86%
Mkt Cap
436.511M
Industry Biotechnology
PRAX Praxis Precision Medicines, Inc.
48.97 +0.76%
Mkt Cap
1.031B
Industry Biotechnology
AKRO Akero Therapeutics, Inc.
47.46 -0.79%
Mkt Cap
3.796B
Industry Biotechnology
MLTX MoonLake Immunotherapeutics
53.95 +2.67%
Mkt Cap
3.426B
Industry Biotechnology
CYTK Cytokinetics, Incorporated
48.29 -0.54%
Mkt Cap
5.778B
Industry Biotechnology
CTMX CytomX Therapeutics, Inc.
2.4100 +14.22%
Mkt Cap
397.44M
Industry Biotechnology
Statistics: CDTX View More
Valuation Measures
Current
Quarterly
Annual
As of 9/23/2025 Market Cap
1.86B
Enterprise Value
1.36B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales
(ttm) --
Price/Book
(mrq) 3.72
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets
(ttm) -23.61%
Return on Equity
(ttm) -37.05%
Revenue
(ttm) --
Net Income Avi to Common
(ttm) -117.1M
Diluted EPS
(ttm) -7.63
Balance Sheet and Cash Flow
Total Cash
(mrq) 510.58M
Total Debt/Equity
(mrq) 0.47%
Levered Free Cash Flow
(ttm) -100.65M
View More
Research Analysis: CDTX View More
Earnings Per Share
Consensus EPS
Revenue vs. Earnings
Revenue --
Earnings -25.72M
Q324
Q424
Q125
Q225
-50M
-40M
-30M
-20M
-10M
0
Analyst Recommendations
Strong Buy
Buy
Hold
Underperform
Sell
Analyst Price Targets
74.00 Low 126.20 Average
88.58 Current
167.00 High
View More
Company Insights: CDTX
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected. Learn More
88.58 Current
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
0 Low
Sector Avg.
100 High
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
0 Low
Sector Avg.
100 High
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
0 Low
Sector Avg.
100 High
People Also Watch
CTMX
CytomX Therapeutics, Inc.
2.4100 +14.22%
CLSD
Clearside Biomedical, Inc.
4.0000 +1.01%
CRVS
Corvus Pharmaceuticals, Inc.
6.48 +5.88%
CFRX
ContraFect Corporation
LPTX
Leap Therapeutics, Inc.
0.3073 +4.03%
Copyright © 2025 Yahoo. All rights reserved.
What's trending Dow Jones
S&P 500
DAX Index
Nvidia
Tesla
DJT
Tariffs
Explore more Mortgages
Credit Cards
Sectors
Crypto Heatmap
Financial News
About Data Disclaimer
Help
Feedback
Sitemap
Licensing
What's New
About Our Ads
Premium Plans
Terms
and Privacy Policy
Privacy Dashboard
More Info
U.S. markets closed
US
Europe
Asia
Cryptocurrencies
Rates
Commodities
Currencies
S&P 500
6,637.97 -18.95 (-0.28%)
Dow 30
46,121.28 -171.50 (-0.37%)
Nasdaq
22,497.86 -75.62 (-0.33%)
Russell 2000
2,434.98 -22.53 (-0.92%)
VIX
16.18 -0.46 (-2.76%)
Gold
3,768.50 -47.20 (-1.24%)
Portfolio
Portfolio
Sign in to access your portfolio Sign in
Top gainers
QURE uniQure N.V. 47.50 +33.84 (+247.73%)
CDTX Cidara Therapeutics, Inc. 88.58 +15.09 (+20.53%)
OPEN Opendoor Technologies Inc. 8.23 +1.15 (+16.24%)
SLNO Soleno Therapeutics, Inc. 64.50 +7.65 (+13.46%)
IREN IREN Limited 47.14 +5.37 (+12.86%)
Top losers
FCX Freeport-McMoRan Inc. 37.67 -7.69 (-16.95%)
QMMM QMMM Holdings Limited 95.00 -14.00 (-12.84%)
WOR Worthington Enterprises, Inc. 53.29 -6.97 (-11.57%)
SOC Sable Offshore Corp. 21.76 -2.73 (-11.15%)
ALAB Astera Labs, Inc. 205.27 -24.84 (-10.79%)
Most active
OPEN Opendoor Technologies Inc. 8.23 +1.15 (+16.24%)
PLUG Plug Power Inc. 2.4000 -0.1300 (-5.14%)
INTC Intel Corporation 31.22 +1.88 (+6.41%)
RGTI Rigetti Computing, Inc. 31.64 +0.20 (+0.64%)
SNAP Snap Inc. 8.22 -0.20 (-2.38%)
Earnings events
My earnings events
Earnings events
Trending tickers
INTC Intel Corporation 31.22 +1.88 (+6.41%)
QURE uniQure N.V. 47.50 +33.84 (+247.73%)
BABA Alibaba Group Holding Limited 176.44 +13.36 (+8.19%)
FCX Freeport-McMoRan Inc. 37.67 -7.69 (-16.95%)
MRVL Marvell Technology, Inc. 80.09 +5.47 (+7.33%)
Top economic events
Top economic events
United States
Mortgage Market Index
Sep 24, 2025, 7:00 AM EDT Prior: P: 386.1 New: N: 388.3
Mortgage Market Index
Sep 24, 2025, 7:00 AM EDT Prior: Prior: 386.1 New: New: 388.3
MBA 30-Yr Mortgage Rate
Sep 24, 2025, 7:00 AM EDT Prior: P: 6.39 New: N: 6.34
MBA 30-Yr Mortgage Rate
Sep 24, 2025, 7:00 AM EDT Prior: Prior: 6.39 New: New: 6.34
Edit your Dock
Terms
and Privacy Policy
Privacy Dashboard
Ad Terms
Feedback
More Info